Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Diabetes Mellitus, Type 2 1 Cushing Syndrome 1 ACTH Syndrome, Ectopic 1

Interventions

Carboplatin 273 Paclitaxel 267 Gemcitabine 244 Bevacizumab 226 Cisplatin 218 pembrolizumab 214 Docetaxel 210 Pemetrexed 162 Capecitabine 148 Fluorouracil 129 Oxaliplatin 121 Cyclophosphamide 121 Nivolumab 112 Dexamethasone 100 Trastuzumab 89 Leucovorin 87 Cetuximab 85 Rituximab 83 Irinotecan 82 Injections 81 Erlotinib Hydrochloride 70 Prednisone 68 Doxorubicin 68 Temozolomide 67 atezolizumab 65 Bortezomib 65 Ipilimumab 64 Fulvestrant 59 Radiotherapy 54 Drug Therapy 51

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × INDUSTRY × ASP3662 × Clear all

NCT07296484 2026-05-12

CAPTAIN-T2D

Sparrow Pharmaceuticals

Phase 2 Recruiting

ACTH Syndrome, Ectopic, Cushing Syndrome, Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡